Press & News
LA JOLLA—The Salk Institute has recruited globally renowned cancer scientist Thales “PapaG” Papagiannakopoulos, PhD, to join its faculty as a professor beginning in September 2026. Papagiannakopoulos has served as a …
LA JOLLA—Salk faculty members Joseph Ecker, PhD, Ronald Evans, PhD, Rusty Gage, PhD, Christian Metallo, PhD, Satchidananda Panda, PhD, Reuben Shaw, PhD, and Kay Tye, PhD, as well as research assistant Joseph Nery have all …
LA JOLLA—El cáncer de páncreas tiene la tasa de mortalidad más alta de todos los cánceres principales, y su incidencia va en aumento. Debido a que típicamente es asintomático en sus etapas tempranas, el cáncer de páncreas es especialmente difícil…
LA JOLLA—Salk Institute Professor Diana Hargreaves was named a 2025 All-Star Translational Award Program grantee by the V Foundation for Cancer Research. The award comes as a recognition of Hargreaves’ …
LA JOLLA—About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main …
LA JOLLA—Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors. It has made an incredible impact on treating cancers in …
LA JOLLA—Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?
Previous studies showed that …
LA JOLLA—The decision between scrambled eggs or an apple for breakfast probably won’t make or break your day. However, for your cells, a decision between similar microscopic nutrients could determine …
LA JOLLA—Within each of our cells, long strands of DNA are folded into chromosomes and capped with protective structures called telomeres. But telomeres shorten as we age, eventually getting so …
LA JOLLA—Salk Institute Assistant Professor Jesse Dixon has been named a 2024 Pew Biomedical Scholar by The Pew Charitable Trusts. This honor provides funding to early-career investigators who demonstrate outstanding …
LA JOLLA—Immunotherapy has revolutionized the way we treat cancer in recent years. Instead of targeting the tumor itself, immunotherapies work by directing patients’ immune systems to attack their tumors more …
LA JOLLA—El Instituto Salk recibirá una donación de $5 millones de dólares durante cuatro años de la Paul M. Angell Family Foundation para apoyar la investigación del cáncer de páncreas. Los líderes del proyecto, la profesora asistente del Salk Dannielle...
LA JOLLA—Salk Institute Professor Susan Kaech has been elected to the U.S. National Academy of Sciences. Kaech is one of 120 new members and 24 international members to be elected …
2023 Padres Pedal the Cause
Padres Pedal the Cause is Curebound’s largest signature event, bringing together thousands of participants each year to raise money for collaborative cancer research. Hosted in partnership with the Padres, “Pedal” is San Diego’s most impactful fundraising experience with over $18 million raised to date to fund 80+ innovative research grants in all types of cancer. This year’s event raised $3,253,032 .
Cancer Research Pilot Grant Portfolio »
